ResearcherEwha Womans UniversityActive in the last 2 years

Yeonjin Kim

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0000-8872-8730; OpenAlex author ID A5101836560. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2025: 1 paper

Papers 1

Cancer-Specific and Pro-Apoptotic PEGylated Liposomes Containing SMAC-Mimetic Doxorubicin Prodrug for Safe High-Dose Delivery in Pancreatic Cancer. Co-author DOI 10.1002/adhm.202502018 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Kwangmeyung Kim · 1 shared paper, 2025 · strength 0.27
- Paper Cancer-Specific and Pro-Apoptotic PEGylated Liposomes Containing SMAC-Mimetic Doxorubicin Prodrug for Safe High-Dose De… DOI 10.1002/adhm.202502018 ↗
Eunsung Jun · 1 shared paper, 2025 · strength 0.27
- Paper Cancer-Specific and Pro-Apoptotic PEGylated Liposomes Containing SMAC-Mimetic Doxorubicin Prodrug for Safe High-Dose De… DOI 10.1002/adhm.202502018 ↗
Inki Kim · 1 shared paper, 2025 · strength 0.27
- Paper Cancer-Specific and Pro-Apoptotic PEGylated Liposomes Containing SMAC-Mimetic Doxorubicin Prodrug for Safe High-Dose De… DOI 10.1002/adhm.202502018 ↗
Ji Hye Jeong · 1 shared paper, 2025 · strength 0.27
- Paper Cancer-Specific and Pro-Apoptotic PEGylated Liposomes Containing SMAC-Mimetic Doxorubicin Prodrug for Safe High-Dose De… DOI 10.1002/adhm.202502018 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.